|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | (2018.01) |
| A61K 38/16 | (2013.01) | ||
| C12Q2600/156 | (2013.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 2995315 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15160169.7 |
| Date of filing the European patent application | 2010-05-14 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 178553 P | 2009-05-15 | US |
| (72) |
Wang, C. Y. Jean , CA
Dick, John , CA
Danska, Jayne , CA
Jin, Liqing , CA
Theocharides, Alexandre , CH
Rajakumar, Sujeetha , CA
|
| (73) |
University Health Network ,
190 Elizabeth Street
R. Fraser Elliott Building - Room 1S-417, Toronto, Ontario M5G 2C4,
CA
The Hospital For Sick Children , 555 University Avenue, Toronto, Ontario M5G 1X8, CA |
| (54) | COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGIC CANCERS TARGETING THE SIRP ALPHA- CD47 INTERACTION |
| COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGIC CANCERS TARGETING THE SIRP ALPHA- CD47 INTERACTION |